253
Views
4
CrossRef citations to date
0
Altmetric
Original Article

A comparison of privileged access interviewing and traditional interviewing methods when studying drug users in treatment

&
Pages 406-415 | Received 23 Jun 2015, Accepted 29 Jan 2016, Published online: 05 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Lisa Andersson & Björn Johnson. (2020) Patient choice as a means of empowerment in opioid substitution treatment: a case from Sweden. Drugs: Education, Prevention and Policy 27:2, pages 105-117.
Read now

Articles from other publishers (3)

Deepak Raj Sharma. (2023) Expert as Interviewer – Methodological Challenges in Use of Qualitative Interviews in Maritime Research. TransNav, the International Journal on Marine Navigation and Safety of Sea Transportation 17:3, pages 637-642.
Crossref
Björn Johnson & Torkel Richert. (2019) Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities. Harm Reduction Journal 16:1.
Crossref
Orlanda Harvey, Steve Keen, Margarete Parrish & Edwin van Teijlingen. (2019) Support for people who use Anabolic Androgenic Steroids: A Systematic Scoping Review into what they want and what they access. BMC Public Health 19:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.